Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Tevogen Bio Holdings ( (TVGN) ).
Tevogen Bio Holdings Inc. has been notified by Nasdaq that it no longer meets the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Global Market. The company has until March 23, 2026, to regain compliance, with potential for an additional 180-day period if necessary. The notification does not immediately affect the company’s listing or trading status, and Tevogen Bio Holdings is actively monitoring its stock price and considering options to address the deficiency.
The most recent analyst rating on (TVGN) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Tevogen Bio Holdings stock, see the TVGN Stock Forecast page.
Spark’s Take on TVGN Stock
According to Spark, TipRanks’ AI Analyst, TVGN is a Underperform.
Tevogen Bio Holdings faces substantial financial risks due to consistent losses and high leverage, which are typical in its industry. Technical analysis indicates a bearish trend, and valuation metrics show speculative investment characteristics. However, the recent corporate event involving a strategic agreement provides a positive outlook for operational advancements, slightly balancing the financial and technical concerns.
To see Spark’s full report on TVGN stock, click here.
More about Tevogen Bio Holdings
Average Trading Volume: 866,057
Technical Sentiment Signal: Sell
Current Market Cap: $152.2M
Learn more about TVGN stock on TipRanks’ Stock Analysis page.